Comerica Securities’s Privia Health PRVA Stock Holding History

Comerica Securities’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18	Closed	-$409	–	1171
2022 Q4	$409	Buy	+18	New	+$501	﹤0.01%	1434

Other funds holding PRVA

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Comerica Securities's PRVA Position: Q1 2023 in Review

Comerica Securities sold out of Privia Health (PRVA) in Q1 2023, closing a stake of 18 shares — an estimated $409 sold.

Comerica Securities first reported a position in PRVA in Q4 2022 and held it in 1 quarter. The position peaked at $409 in Q4 2022. 191 funds tracked by Wall St. Rank hold PRVA as of Q1 2023.

Comerica Securities reported no remaining Privia Health position as of Q1 2023 after selling out during the quarter.
Comerica Securities sold 18 Privia Health shares in Q1 2023, an estimated $409.
Comerica Securities first reported a position in Privia Health in Q4 2022 and held it in 1 quarter.
Comerica Securities's Privia Health position peaked at $409 in Q4 2022.
191 funds tracked by Wall St. Rank held Privia Health as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.